Abstract:Metabolic dysfunction-associated fatty liver disease (MAFLD) is now the most common cause of chronic liver disease worldwide, affecting approximately 30% of the U.S. population and one billion people globally. However, MAFLD often goes undiagnosed due to the lack of reliable clinical indicators and effective screening methods. The current gold standard for diagnosing and assessing MAFLD is through invasive liver biopsy, which is impractical for widespread screening or frequent monitoring. MASLD typically manifests as “macrovesicular steatosis,” characterized by a single large fat vacuole (30-50 µm) in each hepatocyte, representing a more benign and indolent form. However, approximately 20% of MASLD cases exhibit hepatocytes with numerous smaller fat vacuoles (1-15 µm), known as “microvesicular steatosis,” which is linked to a higher risk of steatohepatitis and progression to cirrhosis and cancer. Although ultrasound (US) imaging shows promise as a non-invasive method to assess liver fat content, traditional grayscale features are not sensitive enough to detect mild liver fat or small changes over time. Novel quantitative US-liver fat quantification (QUS-LFQ) tools that analyze acoustic attenuation and backscatter are emerging, with several techniques now available on the market. However, the sensitivity of current QUS-LFQ methods to variations in fat vacuole size remains unknown. While imaging phantoms can help validate these quantitative tools, there is currently no phantom model available that can link US measurements to the severity of steatosis. Existing techniques for modifying material properties such as attenuation, backscatter, and speed of sound do not account for the macro-structure of steatosis, where the size and distribution of scatterers (such as lipid vacuoles) likely influence acoustic wave interactions and thus affect quantitative US liver fat quantification (QUS-LFQ). We developed agar-based phantoms to simulate the excessive fat accumulation and presence of lipid droplets seen in steatotic hepatocytes, using stable micron-sized peanut oil droplets as stand-ins for these lipid vacuoles. Oil microparticles in the 5-20 µm and 20-60 µm size ranges were successfully produced and their stability confirmed. Microscopy and US imaging revealed a uniform distribution of phantom constituents, including oil microparticles, throughout the agar. US-LFQ measurements were accurate, with fat content closely matching theoretical values and those obtained by MRI. Spectral CT measurements demonstrated the expected linear decrease in X-ray attenuation as the lipid content in the phantoms increased. Herein we describe our methods for microparticle formulation and validation.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a tissue - biomimetic model (phantom) capable of simulating liver steatosis for the evaluation and quantification of liver fat content. Specifically, the research aims to address the following key issues: 1. **Lack of reliable non - invasive diagnostic methods**: - Currently, the gold standard for the diagnosis of metabolic - dysfunction - associated fatty liver disease (MAFLD) is through invasive liver biopsy, which is not suitable for large - scale screening or frequent monitoring. - Although traditional ultrasound imaging (US) has the potential as a non - invasive method to assess liver fat content, its gray - scale features are not sensitive enough to mild liver fat or small changes. 2. **Limitations of existing quantitative ultrasound (QUS) tools**: - Existing QUS tools have made progress in analyzing acoustic attenuation and backscattering, but the sensitivity of these tools to different - sized lipid droplets (fat vacuoles) is unclear. - Existing imaging models are unable to relate ultrasound measurement results to the severity of steatosis and do not take into account the influence of the microstructure of fat vacuoles on sound - wave interactions. 3. **Ability to distinguish different types of steatosis**: - Steatosis is divided into two types: macrovesicular and microvesicular. Among them, microvesicular steatosis is associated with a higher risk of inflammation and disease progression. Existing QUS tools have not been able to effectively distinguish these two types. To solve these problems, researchers have developed an agar - based biomimetic model, using stable micron - sized peanut oil droplets to simulate lipid droplets in steatotic hepatocytes. These models can simulate macrovesicular and microvesicular steatosis and can verify the performance of QUS tools in different fat - vacuole sizes and distributions. Through this method, the research hopes to improve the accuracy and reliability of ultrasound imaging in the quantification and classification of fatty liver. ### Key assumptions - By utilizing certain acoustic properties, ultrasound imaging can distinguish between macrovesicular and microvesicular steatosis patterns, thereby achieving the quantification and characterization of steatosis. ### Method overview - **Preparation of oil microparticles**: Oil microparticles of 5 - 20 µm and 20 - 60 µm were prepared respectively to simulate microvesicular and macrovesicular steatosis. - **Preparation of background matrix**: Rectangular - cube - and hockey - puck - shaped background matrices simulating normal non - fatty liver were prepared. - **Preparation of fatty - liver biomimetic model**: Different concentrations of oil microparticles were embedded into the background matrix to form models simulating fatty liver. - **Performance verification**: The biomimetic models were verified by multiple imaging techniques (such as ultrasound, MRI, CT, etc.) to ensure that their performance met expectations. ### Results - The developed biomimetic models can accurately simulate different types of steatosis and show high consistency in imaging techniques such as ultrasound, MRI, and CT. - The oil microparticles in the models are stable and can maintain a uniform distribution at different temperatures. Through these efforts, researchers hope to provide more reliable and standardized tools for future clinical applications to achieve early diagnosis of fatty liver and evaluation of treatment effects.

Tissue-Mimicking Phantom for Liver Fat Quantification

Tissue-Mimicking Phantom for Liver Fat Quantification

Free-breathing liver fat quantification using a multiecho 3D stack-of-radial technique.

Fat Quantification in Dual-Layer Detector Spectral Computed Tomography

Development and evaluation of emulsified reference materials for magnetic resonance imaging

High-fidelity Imaging of Fatty Liver in Vivo with a Fluorescent and Photoacoustic Dual-Mode Probe by Taking Advantage of the Liver “first Pass Effect”

Multiparametric ultrasound imaging for early‐stage steatosis: Comparison with magnetic resonance imaging‐based proton density fat fraction

Potential of Raman-Reflectance Combination in Quantifying Liver Steatosis and Fat Droplet Size: Evidence From Monte Carlo Simulations and Phantom Studies

A preliminary study of liver fat quantification using reported longitudinal ultrasound speed of sound and attenuation parameters

Novel Quantitative Liver Steatosis Assessment Method With Ultrasound Harmonic Imaging

Comparison of different MR fat quantification methods at 3.0 T in a phantom study

Liquid-liver phantom: mimicking the viscoelastic dispersion of human liver for elastography in ultrasound and MRI

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Liver-Quant: Feature-Based Image Analysis Toolkit for Automatic Quantification of Metabolic Dysfunction-Associated Steatotic Liver Disease

Comparative analysis of hepatic fat quantification across 5 T, 3 T and 1.5 T: A study on consistency and feasibility

An ultrasound multiparametric method to quantify liver fat using magnetic resonance as standard reference

Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease

Detecting altered hepatic lipid oxidation by MRI in an animal model of MASLD

Patient-specific ultrasound liver phantom: materials and fabrication method

Assessment of Hepatic Steatosis Using Ultrasound-Based Techniques: Focus on Fat Quantification

Nonalcoholic Fatty Liver Disease: Quantitative Assessment of Liver Fat Content by Computed Tomography, Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy